Care teams at Thomas Jefferson University Hospital were able to decrease time to chemotherapy administration by implementing new strategies within the care team at the inpatient service. According to an abstract from the ASCO Quality Care Symposium, patients with hematologic malignancies are often electively admitted for chemotherapy, and have expressed the desire to start their chemotherapy within 4 hours of arriving at the hospital. ...
Hematology & Blood Cancer
Discover the newest developments in clinical research and treatment for hematologic cancers. Cancer Nursing Today has the latest clinical news and perspectives on CAR T-cell clinical trials, treatment-related blood cancer risks, and more. From screening recommendations to pre-transplant conditioning, learn more about how the field of hematologic oncology is changing.
Advertisement
Latest News
ICANS, a complication of CAR T cell therapy, was associated with an injury that is detectable with a blood test.
The tablet form of blood cancer drug acalabrutinib has been FDA approved, making administration easier for certain patients.
One concern that keeps patients from enrolling in clinical trials is the belief that their quality of life will suffer.
Patients who receive a transplant at a young age may experience GVHD symptoms decades later, like oral chronic GVHD.
Anti-thymocyte globulin (ATG) is used in conditioning prior to allogeneic hematopoietic stem cell transplantation for acute ...
Pivotal trials that supported FDA approval of CAR T-cell therapies had low proportions of Black patients enrolled.
Advertisement
Conference Highlights
Advertisement
Advertisement
Popular Stories
Many studies are examining COVID-19's impact on particular subgroups of patients with cancer.
The new data is being used to develop a biomarker tool to predict the efficacy of neoadjuvant pembrolizumab.
Oncology nurses experience stress from many different directions—time pressures, nursing shortages, complex cancer ...
